SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
夜雨诗意
Lv1
40 积分
2022-05-02 加入
最近求助
最近应助
互助留言
Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes
4天前
已关闭
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
4天前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
4天前
已完结
Gastrin: an acid-releasing, proliferative and immunomodulatory peptide?
5天前
已完结
Gastrin: an acid-releasing, proliferative and immunomodulatory peptide?
5天前
已关闭
Treatment of chronic alopecia areata with tildrakizumab: an open-label pilot study
5天前
已完结
A case of guselkumab-induced alopecia areata
5天前
已完结
Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase-4 inhibitors
5天前
已完结
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
9天前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
12天前
已完结
没有进行任何应助
已找到【积分已退回】
3个月前
帮大忙了
6个月前
感谢
8个月前
感谢
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论